Skip to main content

Michael Walzer's latest

Michael Walzer has a new book out, THE PARADOX OF LIBERATION, from Yale University Press. (And no, the photo here isn't of him.)

I haven't read the book and confess I probably never will: there are just so many books falling off the presses every day....

For many books, even if they seem of interest, I have to settle for an evocative review. For this purpose, a review by an admirer of the author is always preferable (a hostile review can not be relied upon to give a fair summary of the contents).

Fortunately, Walzer -- who has been a figure of importance in US intellectual circles, especially of the leftward sort, for decades -- has an admirer in Michael Ignatieff, who has written a review of this book for the NEW YORK REVIEW OF BOOKS.

The book is about three revolutions/liberations of the mid-twentieth century that, in Walzer's review, started out promisingly and went bad. I'll just quote two paragraphs from the portion of Ignatieff's review devoted to summary:

The paradox of liberation, Walzer argues, is that the liberators looked down on the people they came to liberate. None of Kant's 'crooked timber of humanity' for these revolutionaries; they all believed that the timber made crooked by oppression could be planed straight as a board. Liberation was always an ambiguous project: to free the people from the colonial power and then to free them from their own submissiveness and psychological subjugation.

The Algerian FLN's Soummam conference platform of 1956 positively seethes with scorn toward 'the torpor, fear, and skepticism" if of Algerian population in general. The revolutionary militants of the FLN vowed that they would shock their people into militant consciousness and awaken 'their national dignity' after a century of colonial occupation. If it took bombs and the assassination of collaborators with the French to do that, so be it. Through this trial by fire, Frantz Fanon, the Algerian revolution's leading theorist, proclaimed, "a new Algerian man" would be born.


That is Fanon's photo at the top of this post.


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…